Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bushra Alasmari
Institution:
Ministry of Health
Observed institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Abdulaziz Medical City,
King Abdullah International Medical Research Center,
Ministry of Health,
National Guard Health Affairs
OpenAlex ID:
A5079720933
Hyperkalemia due to topical timolol for hemangioma
2023
·
Bushra Alasmari
, Abdulaziz Alkhenaizan
, et al.
·
JAAD Case Reports
·
7
Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Middle East Fertility Society Journal
·
1
PDF
Correction: Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Middle East Fertility Society Journal
PDF
Additional file 1 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 5 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 3 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 8 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 4 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 6 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 7 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Additional file 2 of Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
2026
·
Norah I. Almanie
, Mehad H. AlQasem
, et al.
·
Figshare
Clinicopathological Profile of Dermatitis Herpetiformis Patients in Saudi Arabia
2024
·
Bushra Alasmari
, Rayan Alkhodair
·
Cureus
Clinicopathological Profile of Dermatitis Herpetiformis Patients in Saudi Arabia
2023
·
Bushra Alasmari
, Rayan Alkhodair
·
Cureus
PDF
Physician Attitude toward Their Attires and Laundering Habit Changes during the COVID-19: A Cross-Sectional Survey in a Tertiary Care Center
2023
·
Reema Alwabel
, Bushra Alasmari
, et al.
·
Avicenna Journal of Medicine
PDF
Show more works
View as search
Works count:
14
Citation count:
8
H-index:
1
I10-index:
Year
Topic
Type